RT Journal Article
SR Electronic
T1 Modeling reductions in SARS-CoV-2 transmission and hospital burden achieved by prioritizing testing using a clinical prediction rule
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.07.20148510
DO 10.1101/2020.07.07.20148510
A1 Reimer, Jody R.
A1 Ahmed, Sharia M.
A1 Brintz, Benjamin
A1 Shah, Rashmee U.
A1 Keegan, Lindsay T.
A1 Ferrari, Matthew J.
A1 Leung, Daniel T.
YR 2020
UL http://medrxiv.org/content/early/2020/07/08/2020.07.07.20148510.abstract
AB Prompt identification of cases is critical for slowing the spread of COVID-19. However, many areas have faced diagnostic testing shortages, requiring difficult decisions to be made regarding who receives a test, without knowing the implications of those decisions on population-level transmission dynamics. Clinical prediction rules (CPRs) are commonly used tools to guide clinical decisions. We used data from electronic health records to develop a parsimonious 5-variable CPR to identify those who are most likely to test positive, and found that its application to prioritize testing increases the proportion of those testing positive in settings of limited testing capacity. To consider the implications of these gains in daily case detection on the population level, we incorporated testing using the CPR into a compartmentalized disease transmission model. We found that prioritized testing led to a delayed and lowered infection peak (i.e. “flattens the curve”), with the greatest impact at lower values of the effective reproductive number (such as with concurrent social distancing measures), and when higher proportions of infectious persons seek testing. Additionally, prioritized testing resulted in reductions in overall infections as well as hospital and intensive care unit (ICU) burden. In conclusion, we present a novel approach to evidence-based allocation of limited diagnostic capacity, to achieve public health goals for COVID-19.One Sentence Summary A clinical prediction rule to prioritize SARS-CoV-2 testing improves daily case detection, flattens and delays the curve, and reduces hospital burden.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis is a modelling study. A clinical trial would be the next step in the implementation of our proposed approach.Funding StatementLTK is supported by the University of Utah 3i Seed award 26798. Funding for MJF was provided by the joint NSF-NIH-NIFA Ecology and Evolution of Infectious Disease award DEB 1911962. RUS is supported by a grant from National Heart Lung and Blood Institute (K08HL136850) and a donation from Women As One. Funding for SMA, BB, LTK, and DTL was provided by NIH grant R01 AI135114 (to DTL).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed by the University of Utah Institutional Review Board (IRB) and determined to be exempt.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code is archived and freely available at doi:10.5281/zenodo.3924186. doi:10.5281/zenodo.3924186